Metabolic-Fit / 100
Spry review
$199/mo semaglutide, $299/mo tirzepatide, three named co-founders (Gabriel Mullins, Sara Yoder, Tyler Bowman), no contracts, and a nurse practitioner reviewing intake within roughly 24 hours by Spry's own claim — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, no pharmacy named, no state list disclosed, and nothing written for postpartum or PCOS specifically. Its pricing appears only once the page's scripts run, never in the visible marketing copy.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Spry at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
How we scored Spry
Every factor comes from Spry's own published pricing, disclosures and oversight, and the six combine into the 38/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Cancellation is workable but not frictionless.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- becomespry.com
$199 for semaglutide and $299 for tirzepatide, confirmed by reading the site's own compiled code because the pages render nothing to a plain fetch. One claim to weigh carefully: Spry displays an 'FDA Approved' badge over compounded medications, which are not themselves FDA-approved finished products. No state list is published.
What to expect when you sign up
We walked Spry's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1On becomespry.com the price is not in the page's own text — it appears only after the page's scripts run
- 2Three co-founders are named on-site: Gabriel Mullins, Sara Yoder, and Tyler Bowman
- 3No contracts required; a nurse practitioner reviews intake within roughly 24 hours per Spry's own claims
- 4Also sells three longevity peptides alongside its GLP-1 program
What we noticed
- Spry's homepage displays an 'FDA Approved' badge and 'FDA-approved treatments' copy — but compounded semaglutide and tirzepatide are not themselves FDA-approved finished drug products; worth reading that badge skeptically
- Three named co-founders is more personal accountability than most compounded-GLP-1 storefronts show
- No state-availability list found, and no pharmacy is named beyond 'FDA-registered compounding facilities' generically
- Nothing on the site addresses pregnancy, breastfeeding, postpartum timing, or PCOS
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | Starting tierConfirmed live on becomespry.com, where the price loads only after the page's scripts run. |
| Compounded tirzepatide | $299 | Starting tierConfirmed the same way. Spry also sells three longevity peptides (BPC-157, NAD+, sermorelin) at $249-$299/mo — not GLP-1s, so left out of these rows rather than mis-tagged. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Spry's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Three named co-founders — more personal accountability than most compounded-GLP-1 storefronts
- No contracts required, with a stated ~24-hour nurse practitioner review of intake
- Also offers three longevity peptides if that's of interest beyond weight loss
The caveats
- Displays an 'FDA Approved' badge over compounded medications that are not themselves FDA-approved finished products
- No pharmacy named, and no state-availability list found
- Nothing written specifically for postpartum, breastfeeding, or PCOS
Spry for mothers: our verdict
$199/mo semaglutide, $299/mo tirzepatide, three named co-founders (Gabriel Mullins, Sara Yoder, Tyler Bowman), no contracts, and a nurse practitioner reviewing intake within roughly 24 hours by Spry's own claim — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, no pharmacy named, no state list disclosed, and nothing written for postpartum or PCOS specifically. Its pricing appears only once the page's scripts run, never in the visible marketing copy. It runs about $199/month, flat across every dose.
We weigh Spry the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Spry costs, in full
- Compounded semaglutide — Starting tier: $199/mo
- Compounded tirzepatide — Starting tier: $299/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
Spry says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Spry prescribes
Spry prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Spry fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Spry is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who likes seeing named founders behind a brand and will read the 'FDA Approved' badge skeptically rather than at face value.
Alternatives to Spry
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Spry
Head-to-head & alternatives
Spry, answered
- How much does Spry cost?
- At last review, Spry's lowest ongoing compounded rate was about $199 a month — $199/mo for semaglutide, $299/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Spry safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. Spry is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does Spry offer both semaglutide and tirzepatide?
- Yes — Spry offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Spry rank for mothers?
- Spry scores 38/100 on our Metabolic-Fit Score and sits at #226. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect Spry's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.